PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Experimental blood test for pancreatic cancer undergoing clinical development and evaluation

Experimental blood test for pancreatic cancer undergoing clinical development and evaluation
2025-01-13
(Press-News.org) GRAND RAPIDS, Mich. (Jan. 13, 2025) — An experimental blood test for pancreatic cancer that was developed by Van Andel Institute and University of Pittsburgh scientists is being evaluated by a commercial laboratory, an important milestone toward making the test available for patients.

A recent double-blinded, peer-reviewed analysis published in Cancer Letters revealed that the experimental test correctly identified 71% of pancreatic cancer samples in the lab compared to only 44% correctly identified by the current gold-standard test. Teams led by VAI Professor Brian Haab, Ph.D., and Randall E. Brand, M.D., a physician-scientist and professor of medicine at the University of Pittsburgh, created the test.

Before the new test can be used by doctors to diagnose cancer, it must undergo clinical validation. During this process, a CLIA-accredited diagnostics laboratory adapts the experimental test into a version that reliably works under the strict conditions in a clinical lab. CLIA is a rigorous federal standard that ensures lab quality.

“Validation studies are essential for transforming a test developed in an academic lab into one that is used to diagnose real people,” Haab said. “For a person being evaluated for pancreatic cancer, the stakes are high. Validation studies ensure that new tests work as intended.”

The new test works by detecting two sugars — CA199.STRA and CA19-9 — that are produced by pancreatic cancer cells and escape into the bloodstream. CA19-9 is the current gold-standard biomarker for pancreatic cancer. Haab’s lab identified CA199.STRA as a cancer biomarker and developed the technology to detect it.

The new test also greatly reduced the number of false negatives while maintaining a low false positive rate, according to the recent analysis. Low rates of false positives and false negatives are important because they reflect the test’s ability to correctly identify the presence or absence of cancer.

Clinical validation of the test will be conducted by ReligenDx, a CLIA-accredited diagnostics lab based in Pennsylvania. The process is expected to take two years.  

If successful in clinical validation, Haab envisions the test being used in two main ways: 1. Catching pancreatic cancer more quickly in people at high risk of the disease, which would enable earlier treatment and 2. Monitoring progression and treatment response in people diagnosed with pancreatic cancer.

Research reported in the Cancer Letters study was supported by the National Cancer Institute of the National Institutes of Health under award nos. U01CA200466 (Brand and Batra), U01CA200468 (Maitra), U01CA152653 (Haab, Allen and Brand), U01CA226158 (Haab and Brand), and U24CA086368 (Zheng, Etzioni and Feng); and the Sheikh Khalifa bin Zayed Foundation (Maitra). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funders.

 

###

ABOUT VAN ANDEL INSTITUTE
Van Andel Institute (VAI) is committed to improving the health and enhancing the lives of current and future generations through cutting-edge biomedical research and innovative educational offerings. Established in Grand Rapids, Michigan, in 1996 by the Van Andel family, VAI is now home to more than 500 scientists, educators and support staff, who work with a growing number of national and international collaborators to foster discovery. The Institute’s scientists study the origins of cancer, Parkinson’s and other diseases and translate their findings into breakthrough prevention and treatment strategies. Our educators develop inquiry-based approaches for K–12 education to help students and teachers prepare the next generation of problem-solvers, while our Graduate School offers a rigorous, research-intensive Ph.D. program in molecular and cellular biology. Learn more at vai.org.

END


[Attachments] See images for this press release:
Experimental blood test for pancreatic cancer undergoing clinical development and evaluation Experimental blood test for pancreatic cancer undergoing clinical development and evaluation 2

ELSE PRESS RELEASES FROM THIS DATE:

Polygamy is (not) for the birds

Polygamy is (not) for the birds
2025-01-13
Researchers at Rice University have uncovered new insights into the evolution of bird behavior, revealing why certain mating systems persist while others disappear over time. In a recent paper published in the journal Evolution, Rafael S. Marcondes and Nicolette Douvas reveal that lekking — a mating system where males display for females without forming lasting bonds — is an evolutionarily stable strategy. In contrast, resource-defense polygamy, where one sex — usually but ...

Hubble reveals surprising spiral shape of galaxy hosting young jet

Hubble reveals surprising spiral shape of galaxy hosting young jet
2025-01-13
The night sky has always played a crucial role in navigation, from early ocean crossings to modern GPS. Besides stars, the United States Navy uses quasars as beacons. Quasars are distant galaxies with supermassive black holes, surrounded by brilliantly hot disks of swirling gas that can blast off jets of material. Following up on the groundbreaking 2020 discovery of newborn jets in a number of quasars, aspiring naval officer Olivia Achenbach of the United States Naval Academy has used NASA’s Hubble Space Telescope to reveal surprising properties of one of them, quasar J0742+2704. "The biggest surprise was seeing the distinct ...

Study: US methamphetamine mortality 61 times higher in '21 than 1999

Study: US methamphetamine mortality 61 times higher in 21 than 1999
2025-01-13
OXFORD, Miss. – Methamphetamine deaths in the U.S. rose 61-fold from 1999 to 2021, according to a new study, highlighting a growing crisis in addiction and public health.  Looking at the gender breakdown of these deaths could improve harm-reduction efforts and outcomes for patients suffering from addiction, said Andrew Yockey, University of Mississippi assistant professor of public health and co-author of the study.   “We know that, across the board, men are more likely to use every substance except tranquilizers than women, and we found that to be true here,” Yockey said. “Especially if we're thinking about methamphetamine, ...

Atop the Oregon Cascades, UO team finds a huge buried aquifer

Atop the Oregon Cascades, UO team finds a huge buried aquifer
2025-01-13
THIS PUBLICATION IS EMBARGOED UNTIL 3 PM EASTERN TIME ON JANUARY 13, 2025. Oregon’s Cascade Range mountains might not hold gold, but they store another precious resource in abundance: water.  Scientists from the University of Oregon and their partners have mapped the amount of water stored beneath volcanic rocks at the crest of the central Oregon Cascades and found an aquifer many times larger than previously estimated — at least 81 cubic kilometers.  That’s almost three times the maximum capacity of Lake Mead, ...

Bay Area community leader champions CPR education and heart health on national platform

2025-01-13
DALLAS, Jan. 13, 2025 — Corey Bentley, an American Heart Association local volunteer and marketing professional in the San Francisco Bay Area, is the Association’s 2024 National Leaders of Impact™ Winner. In the fall of 2024, more than 300 local leaders in 60 communities volunteered to improve heart health while raising funds to fuel the lifesaving mission of the Association, through its nationwide Leaders of Impact campaign. The head-to-head competition doesn’t just focus on raising critical funds. It also supports access to equitable health in local communities given that health inequities related to uncontrolled high blood pressure rates, tobacco ...

Aston University and Birmingham Children’s Hospital study shows diagnosis and treatment of preschool wheeze needs improvement

2025-01-13
Preschool wheeze is a common condition in children under six, affecting 30-40% of children Aston University’s Dr Gemma Heath led a study into parents’ experiences of managing preschool wheeze, including confusion and psychological distress They identified problems with inconsistent terminology and uncertainty around diagnosis and say a unified approach is needed. A study led by Aston University’s Dr Gemma Heath and  Dr Prasad Nagakumar from Birmingham Children’s Hospital, has shown that treatment and diagnosis for preschool wheeze needs more effective ...

Manure management in China cuts river antibiotic pollution but raises groundwater contamination risks

2025-01-13
A recent study published in Environmental Science and Ecotechnology reveals significant changes in antibiotic pollution patterns in China’s water systems over the past decade, driven by evolving manure management practices. Conducted by researchers from China Agricultural University and Wageningen University, the study developed the MARINA-Antibiotics (China-1.0) model to track antibiotic flows from livestock manure into rivers and groundwater across 395 sub-basins between 2010 and 2020. The study found a 59% decrease in antibiotic pollution in rivers, primarily due to improved manure recycling and reduced direct manure discharge into waterways. However, ...

New book provides big recommendations from the Advancing the Science of Cancer in Latinos Conference

2025-01-13
SAN ANTONIO, Jan. 13, 2025 – With cancer still rising in the U.S. Latino population, leaders at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) and national cancer experts have published an online book with innovative recommendations to reduce Latino cancer. The book, “Advancing the Science of Cancer in Latinos: 2024 Conference Proceedings,” highlights results of the same-named conference that brought 300 researchers, advocates and survivors to San Antonio in February 2024. A follow-up conference is planned for Feb. 18-20, 2026, in San Antonio. Included ...

Ash tree variability may offer restoration path post-beetle decimation

Ash tree variability may offer restoration path post-beetle decimation
2025-01-13
UNIVERSITY PARK, Pa. — The invasive emerald ash borer, according to the U.S. Department of Agriculture, was first found in the United States in southeast Michigan in 2002. In the decades since, the wood-boring beetle has spread east and west across the U.S. and Canada, killing tens of millions of ash trees, causing one of the costliest forest insect invasions to date. More than 90% of all ash infested by the insect native to Asia eventually die, threatening to make the tree species functionally extinct in North America. In response, researchers at Penn State are working with the U.S. Forest Service and other partners to identify and develop ...

Integrating CRISPR and biomaterials engineering: Paving the way for safer gene therapies

Integrating CRISPR and biomaterials engineering: Paving the way for safer gene therapies
2025-01-13
CRISPR is a powerful gene-editing tool that holds enormous potential for treating genetic diseases by allowing scientists to cut, replace, or delete mutations in DNA. It can also modify gene expression, temporarily amplifying or diminishing its effects.  Yet, despite its promise, applying CRISPR (which is a reagent, or a substance that facilitates a reaction) in patients presents significant challenges. “CRISPR is difficult to control when you want to do gene editing in vivo, or directly in the patient,” says Tomas Gonzalez-Fernandez, an assistant professor of bioengineering in Lehigh University’s P.C. Rossin College of Engineering ...

LAST 30 PRESS RELEASES:

WVU research reveals adults with disabilities misuse prescription drugs at high rates

Consumers value domestic vanilla -- when informed, research shows

Are higher doses of folic acid in pregnancy safe?

Survey confirms radiation and orthopedic health hazards in cardiac catheterization laboratories are ‘unacceptable’

Study finds consumer devices can be used to assess brain health

Teachers' negative emotions impact engagement of students, new study finds

Researchers see breakthrough with biofuel

White blood cells use brute force to dislodge bacteria

Foundation AI model predicts postoperative risks from clinical notes

Brain functional networks adapt in response to surgery and Botox for facial palsy

Multimodal AI tool supports ecological applications

New University of Minnesota research shows impact of anxiety and apathy on decision-making

Fred Hutch announces 10 recipients of the 2025 Harold M. Weintraub Graduate Student Award

30 million euros for a novel method of monitoring the world's oceans and coastal regions using telecommunications cables

New multicenter study shows: Which treatment helps best with high-risk acute pulmonary embolism

Hidden dangers and myths: What you need to know about HPV and cancer

SNU researchers develop world’s first technology to observe atomic structural changes of nanoparticles in 3D

SNU researchers develop a new synthesis technology of single crystal 2D semiconductors, “Hypotaxy,” to enhance the commercialization of next-generation 2D semiconductors

Graphene production method offers green alternative to mining

Researchers discover a cause of leptin resistance—and how to reverse it

Heat from the sun affects seismic activity on Earth

Postoperative aspiration pneumonia among adults using GLP-1 receptor agonists

Perceived discrimination in health care settings and care delays in patients with diabetes and hypertension

Postoperative outcomes following preweekend surgery

Nearly 4 of 10 Americans report sports-related mistreatment

School absence patterns could ID children with chronic GI disorders, research suggests

Mount Sinai researchers identify molecular glues that protect insulin-producing cells from damage related to diabetes

Study: Smartwatches could end the next pandemic

Equal distribution of wealth is bad for the climate

Evidence-based strategies improve colonoscopy bowel preparation quality, performance, and patient experience 

[Press-News.org] Experimental blood test for pancreatic cancer undergoing clinical development and evaluation